Issue 36, 2013

HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy

Abstract

Here, we report a nanotheranostic system that enables simultaneous imaging and therapy of HER2-overexpressing tumors. We first screened an aptide-based phage library for HER2-specific peptide ligands, identifying a HER2-specific aptide (APTHER2) phage clone. Chemically synthesized APTHER2 showed high affinity for its target protein (Kd ≈ 89 nM) and specifically bound HER2-overexpressing cells (NIH3T6.7) and tumor tissue slices. Next, we prepared HER2-specific-aptide-conjugated magneto-nanoclusters (APTHER2-MNCs) by a rehydration method using oleic acid-stabilized superparamagnetic iron oxide nanoparticles (SPIONs) and amphiphilic phospholipids, yielding nanoparticles with a hydrodynamic diameter of 47 ± 10 nm. The APTHER2-MNCs showed higher transverse (r2) relaxivity (∼180 mM−1 s−1) and greater drug-loading capacity compared to the equivalent isolated SPIONs (∼120 mM−1 s−1). When intravenously injected into HER2-overexpressing NIH3T6.7 tumor-bearing mice, APTHER2-MNCs substantially accumulated in tumor tissue, enhancing the relative signal by ∼45% at 3 h post-injection. This allowed us to detect the tumor using magnetic resonance imaging. Furthermore, after docetaxel loading, the drug-loaded APTHER2-MNCs remarkably inhibited the growth of HER2-overexpressing tumors (∼50% relative to controls) with little apparent toxicity, measured as changes in body weight. Together, these results indicate that APTHER2-MNCs show promise as an efficient nanotheranostic system that enables specific cancer imaging as well as targeted therapy.

Graphical abstract: HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy

Supplementary files

Article information

Article type
Paper
Submitted
29 Apr 2013
Accepted
11 Jul 2013
First published
12 Jul 2013

J. Mater. Chem. B, 2013,1, 4576-4583

HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy

J. Park, S. Park, S. Kim, I. Lee, P. E. Saw, K. Lee, Y. Kim, Y. Kim, O. C. Farokhzad, Y. Y. Jeong and S. Jon, J. Mater. Chem. B, 2013, 1, 4576 DOI: 10.1039/C3TB20613K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements